I. Kubajewska

Limiting the level of tertiary amines on polyamines leads to biocompatible nucleic acid vectors.

A. Schätzlein, I. Uchegbu, J. Moger, 2017, International journal of pharmaceutics.

Cannabinoids and experimental models of multiple sclerosis.

C. Constantinescu, I. Kubajewska, 2010, Immunobiology.

Incorporation of cisplatin into the metal–organic frameworks UiO66-NH2 and UiO66 – encapsulation vs. conjugation

Gareth R. Williams, R. Morris, I. Kubajewska, 2015 .

The potential for a protective vaccine for rhinovirus infections

Gareth R. Williams, S. Johnston, I. Kubajewska, 2016, Expert review of vaccines.

Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes

A. Schätzlein, I. Uchegbu, I. Kubajewska, 2022, Pharmaceutics.

Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure.

A. Schätzlein, I. Uchegbu, I. Kubajewska, 2022, International journal of pharmaceutics.

Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma

John F. Callan, I. Kubajewska, Keith G. Thomas, 2022, Journal of Cancer Research and Clinical Oncology.

The potential for a protective vaccine for rhinovirus infections

Gareth R. Williams, S. Johnston, I. Kubajewska, 2016, Expert review of vaccines.

Limiting the level of tertiary amines on polyamines leads to biocompatible nucleic acid vectors.

A. Schätzlein, I. Uchegbu, J. Moger, 2017, International journal of pharmaceutics.